Complications from Hematopoietic Stem Cell Transplantation that is not Infectious to the Lungs
Received Date: Nov 03, 2022 / Published Date: Nov 28, 2022
Abstract
A prominent cause of morbidity and mortality following hematopoietic stem cell transplant (HSCT) is pulmonary problems. Non-infectious pulmonary problems are becoming a major contributor to transplant-related mortality due to advancements in infection-related complications. Idiopathic pneumonia syndrome (IPS) and bronchiolitis obliterans syndrome (BOS) are the most common early and late consequences, respectively. They can be broadly categorised as either early or late problems. Results from earlier treatments, which mostly consisted of corticosteroids, were frequently poor, stressing the need for a deeper knowledge of the biology of the underlying diseases to direct the adoption of innovative medicines, which are now being used more frequently.
Citation: Nicolson M (2022) Complications from Hematopoietic Stem Cell Transplantation that is not Infectious to the Lungs. J Clin Exp Transplant 7: 150. Doi: 10.4172/2475-7640.1000150
Copyright: © 2022 Nicolson M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 530
- [From(publication date): 0-2022 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 373
- PDF downloads: 157
